Join Our Mailing List

Please join our mailing list to be kept up to date with our latest news, upcoming events, research opportunities and more. Simply complete the form below and you’ll receive our quarterly email newsletter, plus an occasional email in between if there’s something more urgent.

Nephropathic infantile cystinosis is the most common type, accounting for an estimated 95% of cases. People who have late-onset cystinosis generally first develop symptoms in adolescence or early adulthood.

It’s useful for us to know your address so that we can work out the distribution of our supporters throughout the UK, which helps us plan events and advise policy makers.

This is optional. We’ll send you our free welcome pack and may very occasionally contact you by post in the future, but the majority of our communication will always be by email.

Please double-check the details you have entered above, then click the button below to submit the form. We’ll then send you an email with a link to click to confirm your subscription.

We use MailChimp as our marketing automation platform. They process your information on our behalf, in accordance with their Privacy Policy.

If you have any questions or concerns please email

Comments are closed.

Contact: For Families With Disabled Children We’ve recently discovered this organisation that offers a wealth of information, advice [...] Read more...
Latest News and Updates Webinar – 27th November 2021 Please join us on Saturday, 27th November at 2pm for our ‘Latest News and Updates’ [...] Read more...
Cystinosis Comic Book Series by Artist Kevin McCalla The Cystinosis Research Network in the US has teamed up with Kevin McCalla, a young artist who [...] Read more...
Winter 2022 Newsletter The Winter 2022 edition of our email newsletter is available to view at the link below. CFUK [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.